Search for: "Mylan LLC"
Results 121 - 140
of 266
Sort by Relevance
|
Sort by Date
26 Jan 2017, 9:23 am
Mylan Institutional LLC, 137 F. [read post]
16 Jan 2017, 5:44 pm
Alfonso Cioffi, No. 16-200 (holding prosecution history against the patentee) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
7 Dec 2016, 11:58 pm
In addition, last month, the Court of Appeal upheld Arnold J’s findings on the validity of the Patent and the amendment/abuse of process issues but disagreed with him, obiter, on issues concerning the construction and infringement of Swiss Type Claims (Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006). [read post]
18 Nov 2016, 12:44 am
The case also provides a useful comparator for the England and Wales Court of Appeal’s judgment on 13 October 2016 in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (EWCA Judgment) (covered by Brian Cordery of Bristows in ‘Pain and Plausibility – the Lyrica Appeal’), particularly with respect to how Australian and English law determine sufficiency and infringement of Swiss-style claims. [read post]
14 Nov 2016, 9:16 am
Kraft Food Brands Group LLC, No 16-341 (Does the general and broad definition of “residence” found in 28 U.S.C. 1391(c) apply to the patent venue statute 1400(b)) Civil Procedure – Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
24 Oct 2016, 2:35 am
While this moggy was struggling to get back from Indonesia, the Court of Appeal handed down its decision in the pregabalin appeal Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) & Ors [2016] EWCA Civ 1006 (13 October 2016), and finally the IPKat has managed to blog about it (the lateness by no means reflecting on the importance of the judgment).It is very much a judgment of three halves.In the first part of the judgment (up to [135]), which substantively… [read post]
18 Oct 2016, 8:26 am
The following consumer protection actions made headlines this week: Mylan Reaches $465 Million Settlement Over Medicaid Classification On October 7, 2016, Mylan Inc. announced that it had agreed to pay $465 million to resolve a DOJ investigation into Mylan’s classification of EpiPen as a generic drug that resulted in Medicaid and Medicare receiving a significantly smaller rebate on every prescription since 2007. [read post]
17 Oct 2016, 12:11 pm
Author AcdxSource WikipediaCreative Commons Licence Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC [2016] EWCA Civ 1006 (13 Oct 2016) This was an appeal against Mr Justice Arnold's judgment in Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC [2015] EWHC 2548 (Pat) which I discussed in The Pregabalin Trial: Generics (UK) Ltd v Warner-Lambert Company [read post]
13 Oct 2016, 6:50 am
Lee, No. 16-446 (Eligibility of new use of old manufacture – blackjack game) Personal Jurisdiction: Mylan Pharmaceuticals, et al. v. [read post]
28 Sep 2016, 8:39 am
The final new petition is a personal jurisdiction case: Mylan v. [read post]
28 Jun 2016, 6:41 am
Interval Licensing LLC v. [read post]
3 Jun 2016, 6:40 am
; Interval Licensing LLC v. [read post]
18 May 2016, 8:19 am
”) Joao Bock Transaction Systems, LLC v. [read post]
3 May 2016, 1:42 am
Cuozzo Speed Technologies, LLC v. [read post]
18 Apr 2016, 9:58 am
Post Grant Admin: Interval Licensing LLC v. [read post]
1 Apr 2016, 8:22 am
Post Grant Admin: Interval Licensing LLC v. [read post]
30 Mar 2016, 9:59 pm
Mylan Laboratories Ltd. et al. 1:15-cv-00942; filed October 19, 2015 in the District Court of Delaware • Plaintiffs: Fresenius Kabi USA, LLC; Fresenius Kabi Deutschland GmbH • Defendants: Mylan Laboratories Ltd.; Mylan Inc.; Agila Specialties Inc.; Mylan Pharmaceuticals Inc. [read post]
19 Mar 2016, 1:08 am
Mylan Pharma (Fed. [read post]
17 Mar 2016, 2:45 am
Post Grant Admin: Interval Licensing LLC v. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
